Serum Lipid Profile and Oxidative Stress Markers in Patients With Type 2 Diabetes Mellitus

Abstract

Type 2 diabetes mellitus is usually described through glucose, yet two other biochemical stories run alongside it: a characteristic disturbance of the serum lipid profile and a state of heightened oxidative stress. This narrative review asks how these two stories are connected and how much the published literature can support. It draws on work on diabetic dyslipidaemia, on the chemistry and measurement of oxidative stress markers, and on trials of lipid-lowering and antioxidant interventions published up to 2013, and it reports no new data. The usual lipid picture combines raised triglycerides, low high-density lipoprotein cholesterol and small, dense low-density lipoprotein particles that a standard LDL cholesterol value can understate. Oxidative stress in the same patients is often inferred from malondialdehyde-type assays, isoprostanes, protein carbonyls and measures of antioxidant capacity, but these markers differ in specificity and many are sensitive to how blood is handled. Evidence that the two disturbances reinforce each other is biologically coherent and largely observational. Statins have a firm evidence base in diabetes, fibrates a weaker one, and antioxidant vitamins have not delivered the benefit that the oxidative hypothesis predicted. The review concludes that lipid measurement should be read together with particle-level information, that oxidative markers need method-aware interpretation, and that causal claims remain unproven.